Vident Advisory’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Buy |
78,329
+57,597
| +278% | +$890K | 0.01% | 667 |
|
|
2025
Q1 | $308K | Buy |
20,732
+7,126
| +52% | +$106K | ﹤0.01% | 1260 |
|
|
2024
Q4 | $180K | Buy |
13,606
+1,616
| +13% | +$21.4K | ﹤0.01% | 1360 |
|
|
2024
Q3 | $171K | Buy |
11,990
+879
| +8% | +$12.5K | ﹤0.01% | 1341 |
|
|
2024
Q2 | $144K | Buy |
+11,111
| New | +$144K | ﹤0.01% | 1331 |
|
|
2024
Q1 | – | Sell |
-18,713
| Closed | -$267K | – | 1415 |
|
|
2023
Q4 | $267K | Sell |
18,713
-830
| -4% | -$11.8K | 0.01% | 1052 |
|
|
2023
Q3 | $302K | Buy |
+19,543
| New | +$302K | 0.01% | 897 |
|